HoloSolis Secures €220M to Build One of Europe’s Largest Solar Manufacturing Plants
HQ: FR
Founded: 2023
Venture – Series Unknown
Sector: Renewable Energy
Investment Raised: EUR 220m €
Valuation Remains Undisclosed
Investors: Backed by Calés Technologie and Forming, and a solid base of long-standing investors including InnoEnergy, TSE, Groupe IDEC, Armor Group, and Heraeus
Italian biotech AAVantgarde adds $141M series B to fund retinal disease gene therapy trials
HQ: IT
Founded: 2021
Series B
Sector: Biotechnology
Investment Raised: USD 141m €
Valuation Remains Undisclosed
Investors: The raise was led by Atlas Venture, Forbion and a new backer in the form of Schroders. Other new investors who participated in the round include Amgen Ventures, Athos Capital, CDP Venture Capital, Columbia IMC, Neva SGR, Sixty Degree Capital, XGen Venture and Willett Advisors.
Munich-based Tubulis secures €308 million to advance antibody-drug conjugate innovation
HQ: DE
Founded: 2012
Series C
Sector: Biotechnology
Investment Raised: EUR 308m €
Valuation Remains Undisclosed
Investors: Led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital, alongside existing investors including Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, and HTGF.
